Dublin, June 28, 2018 (GLOBE NEWSWIRE) -- The "Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global wound debridement market is projected to grow at a CAGR of 8.2% during the forecast period
The wound debridement market is expected to reach USD 1,041.0 million by 2023 from USD 702.0 million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of burn injuries, and growing awareness programs for wound care treatment and management are driving the growth of the wound debridement market. The main factor hindering overall market growth is the high cost of advanced wound debridement products. Due to this, globally, preference is skewed towards the low-cost products in the market.
The ultrasonic devices segment is estimated to grow at the fastest rate in the next five years
On the basis of product, the wound debridement market is segmented into gels, ointments & creams, surgical devices, ultrasound devices, mechanical debridement pads, medical gauzes, and other wound debridement products. Ultrasonic devices are expected to grow at the highest CAGR during the forecast period due to advantages such as their ability to differentiate between viable and non-viable tissue and their ability to destroy bacteria and biofilms without damaging blood vessels.
In 2018, the autolytic methods segment is expected to dominate the wound debridement market
Based on method, the wound debridement market has been segmented into autolytic, enzymatic, surgical, mechanical, and other methods. In 2018, the autolytic methods segment is expected to register the largest market share during the forecast period. The large share of this segment is primarily due to its advantagesno damage to healthy tissue and ease of use.
Asia Pacific is estimated to grow at the highest CAGR during the study period
Geographically, the wound debridement market is dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to the increasing awareness regarding advanced treatment methods, increasing patient population, and the presence of emerging economies such as China and India.
The key players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mlnlycke Health Care AB (Sweden), and Integra LifeSciences (US).
Companies Mentioned
- B. Braun Melsungen AG
- Coloplast
- Convatec Group
- Deroyal Industries
- Integra Lifesciences
- Lohmann & Rauscher
- Medline Industries
- Misonix
- Mlnlycke Health Care AB
- Smith & Nephew
- Welcare Industries
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Wound Debridement Market Overview
4.2 Asia Pacific: Wound Debridement Market, By Product & Country
4.3 Wound Debridement Market, By Region
4.4 Geographical Snapshot of the Wound Debridement Market (By Major Countries)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Diabetes and Associated Wounds
5.2.1.2 Growth in the Aging Population
5.2.1.3 Rising Incidence of Burn Injuries
5.2.1.4 Awareness Programs for Wound Care Treatment and Management
5.2.2 Market Opportunities
5.2.2.1 Lucrative Opportunities for New Entrants
5.2.2.2 Growth Potential of Emerging Economies
5.2.3 Market Trend
5.2.3.1 Focus on Autolytic Debridement & Disposable Products
6 Wound Debridement Market, By Product
6.1 Introduction
6.2 Gels
6.3 Ointments & Creams
6.4 Surgical Devices
6.5 Medical Gauzes
6.6 Mechanical Debridement Pads
6.7 Ultrasonic Devices
6.8 Other Wound Debridement Products
7 Wound Debridement Market, By Wound Type
7.1 Introduction
7.2 Venous Leg Ulcers
7.3 Diabetic Foot Ulcers
7.4 Pressure Ulcers
7.5 Surgical & Traumatic Wounds
7.6 Burns
7.7 Other Wounds
8 Wound Debridement Market, By Method
8.1 Introduction
8.2 Autolytic Methods
8.3 Enzymatic Methods
8.4 Surgical Methods
8.5 Mechanical Methods
8.6 Other Methods
9 Wound Debridement Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Other End Users
10 Wound Debridement Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Expansions
11.3.2 Product Launches
11.3.3 Collaborations
11.3.4 Acquisitions
12 Company Profiles
12.1 Smith & Nephew
12.2 B. Braun Melsungen AG
12.3 Coloplast
12.4 Misonix
12.5 Convatec Group
12.6 Lohmann & Rauscher
12.7 Deroyal Industries
12.8 Medline Industries
12.9 Mlnlycke Health Care AB
12.10 Integra Lifesciences
12.11 Welcare Industries
For more information about this report visit https://www.researchandmarkets.com/research/3fqcx9/global_1_04?w=12